PubMed · 1990 · 88 citations · 0 references
MedicinePsychiatryPsychologyChild PsychiatryPediatric Mental HealthPsychopharmacologyAnxiety DisordersBehavioral Disorders In ChildhoodChild PsychopharmacologyConduct DisorderPediatric PsychopharmacologyPsychopharmacology In ChildrenChild DepressionChildhood Depressive DisordersConcomitant TherapyDepression Placebo ResponseDifferential Treatment ResponsePatient-reported Symptom ClustersPlacebo Effect In TreatmentTreatment-related Symptom Clusters
Children with pure depression or depression plus an anxiety-related disorder (n = 14) had a higher drug response rate (57%) and a lower placebo response rate (20%) when compared to children with depression plus a concomitant conduct or oppositional disorder (n = 17) (33% drug response rate and 67% placebo response rate). These findings could explain why studies of prepubertal-onset depression found no differences between drug and placebo treatment assuming that a large percentage of the studies' subjects had concomitant conduct or oppositional disorders. The children with pure depression or depression plus an anxiety-related disorder had different symptom clusters from those with depression plus a concomitant conduct or oppositional disorder. The former had more severe CDRS ratings on sleep, appetite disturbance, depressed feelings, and psychomotor retardation. In contrast, those with a concomitant conduct or oppositional disorder had shorter attention spans and were more likely to disturb other children (based on Conners scale scores).